Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 2.54
6.28 %
$ 272 M
Market Cap
-4.88
P/E
ACRS - COST OF REVENUE
Cost of Revenue ACRS - Aclaris Therapeutics, Inc.
18.1 M
LAST VALUE
95.87%
2 YEAR CAGR
21.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR